How This Manufacturer Turned Big Pharma's Commercialization Model Upside Down
When Pfizer acquired Biohaven for $11.6 billion, many big Pharma executives began to question their own beliefs and commercial tactics.
Source: forbes.com
Pharma Commercialization News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Pharma Commercialization. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Pharma Commercialization Today - Breaking & Trending Today
CD&R Creates Global Medical Communications Leader
CD&R Creates Global Medical Communications Leader Huntsworth Acquires Nucleus Global LONDON and NEW YORK, Dec. 11, 2020 /PRNewswire/ -- Huntsworth, a Clayton, Dubilier & Rice portfolio company, has completed the previously announced acquisition of Nucleus Global, creating a global leader in Medical Communications. The terms of the transaction were not disclosed. The combination with Nucleus further establishes Huntsworth as a leading Pharma Commercialization platform, offering a suite of medical affairs, market access, and marketing services to large and mid-size pharmaceutical and biotech c...
Source: finanznachrichten.de